SINTX Technologies (SINT) announced that the United States Patent and Trademark Office issued a Notice of Allowance for a patent application containing method claims covering the Company’s antipathogenic fabric technology. This development builds upon SINTX’s previously announced patent allowance for its Antipathogenic Fibrous Materials composition patent, expanding the Company’s Intellectual Property to protect both the material itself and the processes that bring it to market. This dual coverage strengthens the Company’s competitive advantage, enhances licensing and partnership opportunities, and broadens potential applications across medical textiles, filtration media, and other infection-prone surfaces. These two patent families create a comprehensive IP competitive barrier around SINTX’s surface-level pathogen-inactivation technology, covering applications in wound dressings, surgical drapes and gowns, filtration media, personal protective equipment, and high-touch clinical surfaces.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SINT:
- Sintx Technologies Announces At The Market Offering
- Sintx Technologies files to sell 541,450 shares of common stock for holders
- Sintx Technologies Enters Inducement Agreement for $3.8M
- Why Is Sintx Technologies Stock (SINT) Down 20% Today?
- Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!